ENHANCED LIGATION REACTIONS

In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of at least one agent that generates a ligatable terminal 5′ phosphate group by removing an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodi...

Full description

Saved in:
Bibliographic Details
Main Authors HENDRICKS, Stephen, KING, David, XI, Lei, PERIS, Marian
Format Patent
LanguageEnglish
Published 24.01.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of at least one agent that generates a ligatable terminal 5′ phosphate group by removing an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, an aprataxin enzyme can catalyze removal of an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of an aprataxin enzyme under conditions suitable for ligating nucleic acid ends.
Bibliography:Application Number: US201816154529